“In Silico Assessment of Chemical Constituents of Zingiber officinale Rosc. For Anti-diabetic Activity: Molecular Docking with α-Glucosidase Receptor” (2023) Pharmaceutical and Biomedical Sciences Journal (PBSJ), 5(2), pp. 132–142. doi:10.15408/pbsj.v5i2.36161.